Natural history of successive COPD exacerbations

Thorax

Volumn 67, Issue 11, 2012, Pages 935-936

  Wedzicha, Jadwiga A ^a   Donaldson, Gavin C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HEART FAILURE; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

EID: 84868209412     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202087     Document Type: Editorial

References (15)

1. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007;370:786-96. (Pubitemid 47320802)
2. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
3. Donaldson GC, Seemungal TA, Bhowmik A, et al. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52. (Pubitemid 35178607)
4. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011;365:1184-92.
5. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;63:1128-38.
6. Donaldson GC, Seemungal TA, Bhowmik A, et al. Longitudinal changes in the nature and severity of COPD exacerbations. Eur Respir J 2003;22:931-6. (Pubitemid 37540644)
7. Garcia-Aymerich J, Pons IS, Mannino DM, et al. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011;66:585-90.
8. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of COPD: severe exacerbations and mortality. Thorax 2012;67:957-63.
9. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-13. (Pubitemid 30329036)
10. Bhowmik A, Seemungal TA, Sapsford R, et al. Relation of sputum inflammatory markers to symptoms and physiological changes at COPD exacerbations. Thorax 2000;55:114-20. (Pubitemid 30245950)
11. Patel IS, Seemungal TAR, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations. Thorax 2002;57:759-64. (Pubitemid 34984972)
12. Patel AR, Donaldson GC, Mackay AJ, et al. The impact of ischemic heart disease on symptoms, health status and exacerbations in COPD. Chest 2012;114:851-7.
13. Hurst JR, Donaldson GC, Quint JK, et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:369-74.
14. Roede BM, Bresser P, Bindels PJ, et al. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort. Thorax 2008;63:968-73.
15. Wilkinson TM, Donaldson GC, Hurst JR, et al. Impact of reporting and early therapy on outcome of exacerbations of COPD. Am J Respir Crit Care Med 2004;169:1298-303. (Pubitemid 39571857)